FacebookTwitterGoogle+RedditEmail

What’s the Matter with Oregon?

by FRED GARDNER

“In Corvallis, a very progressive community, there is virtually no doctor who will recommend cannabis for cancer pain or for severe nausea or AIDS.”

-Nurse Ed Glick

Ed Glick was fired April 18 from his job as an acute-care nurse at Samaritan Regional Mental Health Center in Corvallis. He had been employed there for 12 years. The pretext was his refusal to take a drug test. The real reason, Glick thinks, was the pressure he’d been putting on the Oregon Medical Marijuana Program to accept patients with psychiatric diagnoses.

The Oregon Medical Marijuana Act was created by voter initiative in 1998. Unlike California’s law, passed in ’96, which authorizes doctors to recommend marijuana for “any… condition for which marijuana provides relief,” the OMMA created a finite list of qualifying conditions: Cachexia (wasting), Cancer, Glaucoma, HIV+/AIDS, Nausea, Severe Pain, Seizures, including but not limited to epilepsy, and Persistent muscle spasms, including but not limited to those caused by multiple sclerosis.

After OMMA passed, Glick began seeing patients at Samaritan who said they were self-medicating with cannabis to ease various psychiatric symptoms. He would encounter the same people at the Compassion Center in Eugene, where he worked as a volunteer helping patients enroll in the state program. “We assist these people by trying to find a physical correlation to their psychiatric symptom,” Glick explains. “For example, if they’re having PTSD symptoms they might be sick and have physical symptoms.”

Glick attempted to determine how many people were treating psychiatric symptoms by reviewing 172 randomly selected charts. He presented his results at the Patients Out of Time Conference April 8:

“The average patient age was 43. All the patients were registered in OMMA; 95% were registered for pain. (A very large percentage of Oregon registrants are pain patients. Some 40% had multiple qualifying conditions (not including psychiatric) -physical pain and nausea, for example. Pain with spasticity -they often go together.

“The results: 64% of the patients in the survey showed some kind of significant psychiatric benefit; 39% reported insomnia relief; 5% reported PTSD symptom relief, many of them veterans who go to the VA hospital in Roseburg and are denied. The VA doctors tell them ‘No, I can’t. I’ll lose my DEA license.’ They just don’t want to stand up to it -although they’re beginning to refer patients to us, which is kind of interesting.

“Anxiety, 11%; depressive symptoms, 11%; 15% of the cohort reported that they were using cannabis to decrease the side effects of medications; 56% reported reduced use of medications.

“What these patients report to me is that they’re sick and tired of Vioxx and they’re sick and tired of Flexeril, Vicodin -people are literally sick of these drugs. They can’t sleep, they can’t function, they’re drugged up, they don’t have any enjoyment of life. When they start using cannabis they leave off the Vioxx and they leave off the Vicodin. Vicodin has a place, but for long-term pain management it is really poor. Appetite stimulation -tremendously important for people who are in pain all the time- was 20%.

“I put the survey together as a request to the Oregon Department of Human Services to reconvene the Debilitating Conditions Advisory Panel, which I was a member of in 2000. At that time nine patients had submitted requests to include psychiatric conditions to the list. The state health officer did a fairly good job of bringing together the panel, but the whole thing was skewed from the outset by political manipulation by the governor’s office and by the head of the Department of Health Services. The information that they would allow us to consider had to be filtered through rules stating that if it’s not a double-blind, peer-reviewed clinical trial, it doesn’t get a lot of evidentiary weight.

“We were not allowed to give much weight to patients’ reports. And of course there was no relevant double-blind, peer-reviewed clinical trial. So the panel was set up to fail. A few patients came in and gave very compelling testimonials. And then out of nowhere came a whole bunch of medical experts -psychiatrists from Oregon Health Sciences University and the National Alliance for the Mentally Ill- and they just had fits. “This is quackery,” they said.

“The only person who even differentiated between affective depressive-type disorders and schizophrenic thought disorders was one of the patients. None of the doctors even made any differentiation between these two completely different sets of medical problems. After a long, protacted time we all wrote our comments out, and there was a vote, and we voted to add affective disorders -severe agitation and depressive symptoms. Didn’t happen. They finally did add Alzheimer’s agitation. [Fewer than 50 patients have qualified to date for Alzheimer’s agitation.]

“So, five years later I brought in the study I’d done with OMMP registrants and asked them to reconvene the Debilitating Conditions Panel based on this new evidence showing that indeed there is some psychiatric effect that people are getting from their cannabis use. And they rejected the request with a ‘summary denial.’

“Then Lee Berger, an attorney in Portland, asked if I’d be willing to sue the Department of Human Services’ OMMP and I said yes. We filed our petition for judicial review in February -a formal request ‘to Add Clinical Depression, Depressive Symptoms, Post-Traumatic Stress Disorder (PTSD), Severe Anxiety, Agitation and Insomnia, to Those Diseases and Conditions Which Qualify as “Debilitating Medical Conditions” under the Oregon Medical Marijuana Act.’ And it worked! I can’t believe it!

“We got word in late March that, because the OMMP doesn’t really want to go to court, they’ve decided to kind of sue for peace. All we’re asking is that they reconvene a panel to evaluate these conditions. So, we’re in the process of negotiating with them to get this thing back on track.

“We want to close some of the loopholes that allow them to skew the evidence base. It’s pretty clear that there are a lot of patients who are using cannabis for insomnia, for mood stabilizing, and for peace. Just for a a very simple, elemental peace, especially with chronic diseases like severe chronic pain. Cannabis is actually a miracle drug for pain, in my opinion.

“There’s no question the last thing the pharmacy industry wants is millions and millions of Americans growing and using their own medicine that covers such a wide array of diseases.”

Glick was fired 10 days after giving this account to Patients Out of Time. Perhaps someone at the Oregon Health Sciences University, the dominant institution in Corvallis, did not like the effrontery of a Samaritan nurse criticizing their prestigious “experts.”

 

Washburn Can’t Get His Job Back

The Oregon Supreme Court has ruled against Robert Washburn, a Klamath Falls millworker fired by Columbia Forest Products in 2001 after he tested positive for marijuana. Washburn had a card from the OMMP and used marijuana at home (not “in” the workplace) for insomnia stemming from muscle pain. Before getting his card in 1999 Washburn had been using prescription painkillers. He says that marijuana is more effective and exerts no adverse effects. He requested that the company give him a test to determine if he was actually impaired on the job (rather than one that detects metabolites in the urine). This, his lawyer argued, would be a reasonable accommodation under Oregon’s statute protecting the disabled from discrimination in the workplace. When the company refused, Washburn sued for reinstatement and back pay.

A Multnomah County Circuit Court judge ruled against Washburn, citing a clause in OMMA saying the act shall not be construed to require “an employer to accommodate use of medical marijuana in the workplace.” The Court of Appeals then ruled for Washburn and Columbia Forest Products took the case to the state supreme court, which heard arguments in November. Now the Supremes have ruled unanimously that Washburn does not qualify as disabled because the prescription drugs enabled him to sleep (albeit less well and with more side effects than marijuana).

According to Chief Justice Paul De Muniz, Washburn’s pain-related sleep problems did not constitute a “substantial limitation” justifying the use of marijuana. In a concurring opinion, Justice Rives Kistler cited the U.S. Supreme Court ruling in the Raich case that the federal Controlled Substances Act prohibits marijuana possession and use, even for medical purposes.

The state supreme court ruling against Washburn is “narrow” in the sense that workers with more severe disabilities might yet assert the rights he was denied. But attorney Phil Lebenbaum, expressed concern that the ruling limits the definition of a disability, and may affect workers in cases having nothing to with marijuana.

Willamette Weak

Reform advocate Don DuPay, running for Sheriff of Multnomah county, got 31% of the vote (on a budget of $485), despite being dissed by the Portland media. DuPay is a former Portland cop who has worked extensively with recovering addicts and alcoholics. “Willamette Week was the first paper to talk to me,” he recounts. “I spent an hour talking to four of their reporters, explaining my ideas about community policing, getting rid of tasers, getting rid of the SWAT-team-style uniforms, creating a Wapato Treatment center, giving back $30,000 of my salary to social services. ‘Thank you Mister DuPay for coming in,’ they said, ‘And by the way, what kind of a car do you drive?’

“What they printed was that I was a 69-year-old marijuana-smoking grandfather with a cult-following from the Cannabis Common Sense TV Show. Is that all those reporters heard? They went on to endorse a write-in candidate unqualified to take office.” Alternative media, indeed.
Can’t You Say Something Positive?

Bees and butterflies were sighted in the Willamette Valley on our O’Shaughnessy’s distribution run. This may mean that the organic movement is reducing the tonnage of pesticides and herbicides drenching that luscious topsoil D.O., the osteopaths’ journal, has a cover story on cannabis in which Philip Leveque (whose license was revoked by the Oregon Board of Medical Examiners) is one of two advocates for the herb in a debate against 12 nay-sayers. Leveque says he’s heard that some 200 Oregon osteopaths have issued letters of approval for their patients to medicate with cannabis.

FRED GARDNER is the editor of O’Shaughnessy’s Journal of the California Cannabis Research Medical Group. He can be reached at: fred@plebesite.com

 

 

Fred Gardner is the managing editor of O’Shaughnessy’s. He can be reached at fred@plebesite.com

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

Weekend Edition
January 20, 2017
Friday - Sunday
Paul Street
Divide and Rule: Class, Hate, and the 2016 Election
Andrew Levine
When Was America Great?
Jeffrey St. Clair
Roaming Charges: This Ain’t a Dream No More, It’s the Real Thing
Yoav Litvin
Making Israel Greater Again: Justice for Palestinians in the Age of Trump
Linda Pentz Gunter
Nuclear Fiddling While the Planet Burns
Ruth Fowler
Standing With Standing Rock: Of Pipelines and Protests
David Green
Why Trump Won: the 50 Percenters Have Spoken
Dave Lindorff
Imagining a Sanders Presidency Beginning on Jan. 20
Pete Dolack
Eight People Own as Much as Half the World
Roger Harris
Too Many People in the World: Names Named
Steve Horn
Under Tillerson, Exxon Maintained Ties with Saudi Arabia, Despite Dismal Human Rights Record
John Berger
The Nature of Mass Demonstrations
Stephen Zielinski
It’s the End of the World as We Know It
David Swanson
Six Things We Should Do Better As Everything Gets Worse
Alci Rengifo
Trump Rex: Ancient Rome’s Shadow Over the Oval Office
Brian Cloughley
What Money Can Buy: the Quiet British-Israeli Scandal
Mel Gurtov
Donald Trump’s Lies And Team Trump’s Headaches
Kent Paterson
Mexico’s Great Winter of Discontent
Norman Solomon
Trump, the Democrats and the Logan Act
David Macaray
Attention, Feminists
Yves Engler
Demanding More From Our Media
James A Haught
Religious Madness in Ulster
Dean Baker
The Economics of the Affordable Care Act
Patrick Bond
Tripping Up Trumpism Through Global Boycott Divestment Sanctions
Robert Fisk
How a Trump Presidency Could Have Been Avoided
Robert Fantina
Trump: What Changes and What Remains the Same
David Rosen
Globalization vs. Empire: Can Trump Contain the Growing Split?
Elliot Sperber
Dystopia
Dan Bacher
New CA Carbon Trading Legislation Answers Big Oil’s Call to Continue Business As Usual
Wayne Clark
A Reset Button for Political America
Chris Welzenbach
“The Death Ship:” An Allegory for Today’s World
Uri Avnery
Being There
Peter Lee
The Deep State and the Sex Tape: Martin Luther King, J. Edgar Hoover, and Thurgood Marshall
Patrick Hiller
Guns Against Grizzlies at Schools or Peace Education as Resistance?
Randy Shields
The Devil’s Real Estate Dictionary
Ron Jacobs
Singing the Body Electric Across Time
Ann Garrison
Fifty-five Years After Lumumba’s Assassination, Congolese See No Relief
Christopher Brauchli
Swing Low Alabama
Dr. Juan Gómez-Quiñones
La Realidad: the Realities of Anti-Mexicanism
Jon Hochschartner
The Five Least Animal-Friendly Senate Democrats
Pauline Murphy
Fighting Fascism: the Irish at the Battle of Cordoba
Susan Block
#GoBonobos in 2017: Happy Year of the Cock!
Louis Proyect
Is Our Future That of “Sense8” or “Mr. Robot”?
Charles R. Larson
Review: Robert Coover’s “Huck out West”
David Yearsley
Manchester-by-the-Sea and the Present Catastrophe
FacebookTwitterGoogle+RedditEmail